BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22173241)

  • 1. Digital gene expression profiling of primary acute lymphoblastic leukemia cells.
    Nordlund J; Kiialainen A; Karlberg O; Berglund EC; Göransson-Kultima H; Sønderkær M; Nielsen KL; Gustafsson MG; Behrendtz M; Forestier E; Perkkiö M; Söderhäll S; Lönnerholm G; Syvänen AC
    Leukemia; 2012 Jun; 26(6):1218-27. PubMed ID: 22173241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
    Davies C; Hogarth LA; Dietrich PA; Bachmann PS; Mackenzie KL; Hall AG; Lock RB
    J Biol Chem; 2011 Oct; 286(43):37639-50. PubMed ID: 21903579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
    Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
    Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
    Haouas H; Haouas S; Uzan G; Hafsia A
    Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
    James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
    J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
    Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
    Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemia.
    Milani L; Lundmark A; Kiialainen A; Nordlund J; Flaegstad T; Forestier E; Heyman M; Jonmundsson G; Kanerva J; Schmiegelow K; Söderhäll S; Gustafsson MG; Lönnerholm G; Syvänen AC
    Blood; 2010 Feb; 115(6):1214-25. PubMed ID: 19965625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD304/neuropilin-1 is a very useful and dependable marker for the measurable residual disease assessment of B-cell precursor acute lymphoblastic leukemia.
    Gudapati P; Khanka T; Chatterjee G; Ghogale S; Badrinath Y; Deshpande N; Patil J; Narula G; Shetty D; Banavali S; Patkar NV; Gujral S; Subramanian PG; Tembhare PR
    Cytometry B Clin Cytom; 2020 Jul; 98(4):328-335. PubMed ID: 31944572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.
    Malumbres R; Fresquet V; Roman-Gomez J; Bobadilla M; Robles EF; Altobelli GG; Calasanz MJ; Smeland EB; Aznar MA; Agirre X; Martin-Palanco V; Prosper F; Lossos IS; Martinez-Climent JA
    Haematologica; 2011 Jul; 96(7):980-6. PubMed ID: 21459790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA microarrays for comparison of gene expression profiles between diagnosis and relapse in precursor-B acute lymphoblastic leukemia: choice of technique and purification influence the identification of potential diagnostic markers.
    Staal FJ; van der Burg M; Wessels LF; Barendregt BH; Baert MR; van den Burg CM; van Huffel C; Langerak AW; van der Velden VH; Reinders MJ; van Dongen JJ
    Leukemia; 2003 Jul; 17(7):1324-32. PubMed ID: 12835720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nationwide study of pediatric B-cell precursor acute lymphoblastic leukemia with chromosome 8q24/MYC rearrangement in Japan.
    Sakaguchi K; Imamura T; Ishimaru S; Imai C; Shimonodan H; Fujita N; Okada K; Taketani T; Kanai R; Tauchi H; Kato M; Kojima Y; Watanabe A; Deguchi T; Hashii Y; Kiyokawa N; Taki T; Saito AM; Horibe K; Manabe A; Sato A; Koh K
    Pediatr Blood Cancer; 2020 Jul; 67(7):e28341. PubMed ID: 32323914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell acute lymphoblastic leukemia in infants has distinct genetic and epigenetic features compared to childhood cases.
    Doerrenberg M; Kloetgen A; Hezaveh K; Wössmann W; Bleckmann K; Stanulla M; Schrappe M; McHardy AC; Borkhardt A; Hoell JI
    Genes Chromosomes Cancer; 2017 Feb; 56(2):159-167. PubMed ID: 27717083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential WNT gene expression in various subtypes of acute lymphoblastic leukemia.
    Memarian A; Vosough P; Asgarian-Omran H; Tabrizi M; Shabani M; Shokri F
    Iran J Immunol; 2012 Mar; 9(1):61-71. PubMed ID: 22426169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very long intergenic non-coding RNA transcripts and expression profiles are associated to specific childhood acute lymphoblastic leukemia subtypes.
    Caron M; St-Onge P; Drouin S; Richer C; Sontag T; Busche S; Bourque G; Pastinen T; Sinnett D
    PLoS One; 2018; 13(11):e0207250. PubMed ID: 30440012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3D and PRKCQ work together to discriminate between B-cell and T-cell acute lymphoblastic leukemia.
    Ma D; Zhong S; Liu X; Mai H; Mai G; Xu C; Zhou F
    Comput Biol Med; 2016 Oct; 77():16-22. PubMed ID: 27494091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
    Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
    Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL).
    Mavrakis KJ; Van Der Meulen J; Wolfe AL; Liu X; Mets E; Taghon T; Khan AA; Setty M; Rondou P; Vandenberghe P; Delabesse E; Benoit Y; Socci NB; Leslie CS; Van Vlierberghe P; Speleman F; Wendel HG
    Nat Genet; 2011 Jun; 43(7):673-8. PubMed ID: 21642990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
    Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
    Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.